Research ArticleArticle
Anticyclic Citrullinated Peptide Antibodies and Rheumatoid Factor as Risk Factors for 10-year Cardiovascular Morbidity in Patients with Rheumatoid Arthritis: A Large Inception Cohort Study
Mike L.T. Berendsen, Marissa C. van Maaren, Elke E.A. Arts, Alfons A. den Broeder, Calin D. Popa and Jaap Fransen
The Journal of Rheumatology July 2017, jrheum.160670; DOI: https://doi.org/10.3899/jrheum.160670
Mike L.T. Berendsen
From the Department of Rheumatology, Radboud University Medical Centre; Department of Rheumatology, St. Maartenskliniek, Nijmegen; Department of Rheumatology, Bernhoven Hospital, Uden, the Netherlands. M.L. Berendsen, MSc, Department of Rheumatology, Radboud University Medical Centre; M.C. van Maaren, MSc, Department of Rheumatology, Radboud University Medical Centre; E.E. Arts, MD, PhD, Department of Rheumatology, Radboud University Medical Centre; A.A. den Broeder, PhD, Department of Rheumatology, St. Maartenskliniek; C.D. Popa, MD, PhD, Department of Rheumatology, Radboud University Medical Centre, and Department of Rheumatology, Bernhoven Hospital; J. Fransen, PhD, Department of Rheumatology, Radboud University Medical Centre. M.L. Berendsen and M.C. van Maaren contributed equally to this work. Address correspondence to Dr. C.D. Popa, Department of Rheumatology, Radboud University Medical Centre, P.O. Box 9101, 6500 HB Nijmegen, the Netherlands. E-mail: calin.popa@radboudumc.nl. Accepted for publication April 26, 2017.
Marissa C. van Maaren
From the Department of Rheumatology, Radboud University Medical Centre; Department of Rheumatology, St. Maartenskliniek, Nijmegen; Department of Rheumatology, Bernhoven Hospital, Uden, the Netherlands. M.L. Berendsen, MSc, Department of Rheumatology, Radboud University Medical Centre; M.C. van Maaren, MSc, Department of Rheumatology, Radboud University Medical Centre; E.E. Arts, MD, PhD, Department of Rheumatology, Radboud University Medical Centre; A.A. den Broeder, PhD, Department of Rheumatology, St. Maartenskliniek; C.D. Popa, MD, PhD, Department of Rheumatology, Radboud University Medical Centre, and Department of Rheumatology, Bernhoven Hospital; J. Fransen, PhD, Department of Rheumatology, Radboud University Medical Centre. M.L. Berendsen and M.C. van Maaren contributed equally to this work. Address correspondence to Dr. C.D. Popa, Department of Rheumatology, Radboud University Medical Centre, P.O. Box 9101, 6500 HB Nijmegen, the Netherlands. E-mail: calin.popa@radboudumc.nl. Accepted for publication April 26, 2017.
Elke E.A. Arts
From the Department of Rheumatology, Radboud University Medical Centre; Department of Rheumatology, St. Maartenskliniek, Nijmegen; Department of Rheumatology, Bernhoven Hospital, Uden, the Netherlands. M.L. Berendsen, MSc, Department of Rheumatology, Radboud University Medical Centre; M.C. van Maaren, MSc, Department of Rheumatology, Radboud University Medical Centre; E.E. Arts, MD, PhD, Department of Rheumatology, Radboud University Medical Centre; A.A. den Broeder, PhD, Department of Rheumatology, St. Maartenskliniek; C.D. Popa, MD, PhD, Department of Rheumatology, Radboud University Medical Centre, and Department of Rheumatology, Bernhoven Hospital; J. Fransen, PhD, Department of Rheumatology, Radboud University Medical Centre. M.L. Berendsen and M.C. van Maaren contributed equally to this work. Address correspondence to Dr. C.D. Popa, Department of Rheumatology, Radboud University Medical Centre, P.O. Box 9101, 6500 HB Nijmegen, the Netherlands. E-mail: calin.popa@radboudumc.nl. Accepted for publication April 26, 2017.
Alfons A. den Broeder
From the Department of Rheumatology, Radboud University Medical Centre; Department of Rheumatology, St. Maartenskliniek, Nijmegen; Department of Rheumatology, Bernhoven Hospital, Uden, the Netherlands. M.L. Berendsen, MSc, Department of Rheumatology, Radboud University Medical Centre; M.C. van Maaren, MSc, Department of Rheumatology, Radboud University Medical Centre; E.E. Arts, MD, PhD, Department of Rheumatology, Radboud University Medical Centre; A.A. den Broeder, PhD, Department of Rheumatology, St. Maartenskliniek; C.D. Popa, MD, PhD, Department of Rheumatology, Radboud University Medical Centre, and Department of Rheumatology, Bernhoven Hospital; J. Fransen, PhD, Department of Rheumatology, Radboud University Medical Centre. M.L. Berendsen and M.C. van Maaren contributed equally to this work. Address correspondence to Dr. C.D. Popa, Department of Rheumatology, Radboud University Medical Centre, P.O. Box 9101, 6500 HB Nijmegen, the Netherlands. E-mail: calin.popa@radboudumc.nl. Accepted for publication April 26, 2017.
Calin D. Popa
From the Department of Rheumatology, Radboud University Medical Centre; Department of Rheumatology, St. Maartenskliniek, Nijmegen; Department of Rheumatology, Bernhoven Hospital, Uden, the Netherlands. M.L. Berendsen, MSc, Department of Rheumatology, Radboud University Medical Centre; M.C. van Maaren, MSc, Department of Rheumatology, Radboud University Medical Centre; E.E. Arts, MD, PhD, Department of Rheumatology, Radboud University Medical Centre; A.A. den Broeder, PhD, Department of Rheumatology, St. Maartenskliniek; C.D. Popa, MD, PhD, Department of Rheumatology, Radboud University Medical Centre, and Department of Rheumatology, Bernhoven Hospital; J. Fransen, PhD, Department of Rheumatology, Radboud University Medical Centre. M.L. Berendsen and M.C. van Maaren contributed equally to this work. Address correspondence to Dr. C.D. Popa, Department of Rheumatology, Radboud University Medical Centre, P.O. Box 9101, 6500 HB Nijmegen, the Netherlands. E-mail: calin.popa@radboudumc.nl. Accepted for publication April 26, 2017.
Jaap Fransen
From the Department of Rheumatology, Radboud University Medical Centre; Department of Rheumatology, St. Maartenskliniek, Nijmegen; Department of Rheumatology, Bernhoven Hospital, Uden, the Netherlands. M.L. Berendsen, MSc, Department of Rheumatology, Radboud University Medical Centre; M.C. van Maaren, MSc, Department of Rheumatology, Radboud University Medical Centre; E.E. Arts, MD, PhD, Department of Rheumatology, Radboud University Medical Centre; A.A. den Broeder, PhD, Department of Rheumatology, St. Maartenskliniek; C.D. Popa, MD, PhD, Department of Rheumatology, Radboud University Medical Centre, and Department of Rheumatology, Bernhoven Hospital; J. Fransen, PhD, Department of Rheumatology, Radboud University Medical Centre. M.L. Berendsen and M.C. van Maaren contributed equally to this work. Address correspondence to Dr. C.D. Popa, Department of Rheumatology, Radboud University Medical Centre, P.O. Box 9101, 6500 HB Nijmegen, the Netherlands. E-mail: calin.popa@radboudumc.nl. Accepted for publication April 26, 2017.
In this issue
The Journal of Rheumatology
Vol. 51, Issue 3
1 Mar 2024
Anticyclic Citrullinated Peptide Antibodies and Rheumatoid Factor as Risk Factors for 10-year Cardiovascular Morbidity in Patients with Rheumatoid Arthritis: A Large Inception Cohort Study
Mike L.T. Berendsen, Marissa C. van Maaren, Elke E.A. Arts, Alfons A. den Broeder, Calin D. Popa, Jaap Fransen
The Journal of Rheumatology Jul 2017, jrheum.160670; DOI: 10.3899/jrheum.160670
Anticyclic Citrullinated Peptide Antibodies and Rheumatoid Factor as Risk Factors for 10-year Cardiovascular Morbidity in Patients with Rheumatoid Arthritis: A Large Inception Cohort Study
Mike L.T. Berendsen, Marissa C. van Maaren, Elke E.A. Arts, Alfons A. den Broeder, Calin D. Popa, Jaap Fransen
The Journal of Rheumatology Jul 2017, jrheum.160670; DOI: 10.3899/jrheum.160670